1. Home
  2. STVN vs CHE Comparison

STVN vs CHE Comparison

Compare STVN & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$15.88

Market Cap

5.4B

ML Signal

HOLD

CHE

Chemed Corp

HOLD

Current Price

$472.44

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STVN
CHE
Founded
1949
1970
Country
Employees
N/A
N/A
Industry
Containers/Packaging
Medical/Nursing Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STVN
CHE
Price
$15.88
$472.44
Analyst Decision
Hold
Buy
Analyst Count
2
4
Target Price
$23.75
$555.50
AVG Volume (30 Days)
1.0M
170.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.40%
0.51%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.42
$5.91
Revenue Next Year
$9.61
$6.06
P/E Ratio
$26.70
$24.96
Revenue Growth
N/A
N/A
52 Week Low
$13.91
$408.42
52 Week High
$28.00
$623.61

Technical Indicators

Market Signals
Indicator
STVN
CHE
Relative Strength Index (RSI) 40.83 68.51
Support Level $15.43 $443.33
Resistance Level $16.69 $458.93
Average True Range (ATR) 0.99 11.60
MACD 0.19 3.31
Stochastic Oscillator 60.60 85.18

Price Performance

Historical Comparison
STVN
CHE

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Share on Social Networks: